F.Y. Feng

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)”.

FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.401

N/A

0DataRank · unranked

3 citations

Marisa Kollmeier, Dana E. Rathkopf, Richard M. Hoffman, A. Zurita-Saavedra, Daniel E. Spratt +15 more

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

Annals of Oncology(2025)10.1016/j.annonc.2025.01.017

N/A

0DataRank · unranked

16 citations

Pirus Ghadjar, Hyunnam Ryu, J.A. Proudfoot, Stefanie Hayoz, J.M. Michalski +28 more